<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>HA-COL™ | Redefining ECM for Organoid Innovation</title>
  <link rel="stylesheet" href="style.css" />
</head>
<body>
  <header>
    <h1>HA-COL™</h1>
    <p>Redefining Extracellular Matrices for Human Organoids and Preclinical Testing</p>
  </header>

  <nav>
    <a href="technology.html">Technology</a>
    <a href="products.html">Products</a>
    <a href="investors.html">Investors</a>
    <a href="contact.html">Contact</a>
  </nav>

  <section class="hero">
    <h2>The Future of Organoid ECM is Here</h2>
    <p>HA-COL™ is Australia’s first defined, human-relevant ECM hydrogel platform, offering clean, tunable, bioprintable matrices for organoid culture, drug testing, and beyond.</p>
    <div class="cta-buttons">
      <a href="products.html">Explore Products</a>
      <a href="investors.html">Investor Info</a>
    </div>
  </section>

  <section class="features">
    <div class="feature">
      <h3>Defined & Reproducible</h3>
      <p>Unlike Matrigel®, HA-COL™ offers consistent batch-to-batch composition suitable for pharma and academic research.</p>
    </div>
    <div class="feature">
      <h3>Bioprinting Ready</h3>
      <p>Our HA-COL™ BioInk enables layered printing for custom organoid models and barrier tissues.</p>
    </div>
    <div class="feature">
      <h3>Commercial & Clinical Path</h3>
      <p>RUO ready now, GMP scalability soon — HA-COL™ is your translational ECM partner.</p>
    </div>
  </section>

  <footer>
    &copy; 2025 HA-COL Biotech. All rights reserved. | Designed in Australia | Contact: info@ha-col.com
  </footer>
</body>
</html>
